Pancreatic Panniculitis Mimicking Bilateral Cellulitis: A Case Report

Jessie M Nelson,Albert T Young,Sree S Kolli,Ben J Friedman,Holly A Kerr

DOI: https://doi.org/10.1093/ced/llae071

2024-03-02

Clinical and Experimental Dermatology

Abstract:This case illustrates a unique initial presentation of pancreatic panniculitis mimicking bilateral cellulitis. A novel possible association with semaglutide is discussed.

dermatology

What problem does this paper attempt to address?

A Case of Bullous Eosinophilic Cellulitis

Xiaoyun JIANG,Rui HAN,Jun YE,Hao CHENG

DOI: https://doi.org/10.13735/j.cjdv.1001-7089.201709104

2018-01-01

Abstract:A 29-year-old male patient presented with erythema and papules along with itching more than 2 months, and the symptoms aggravated for 3 days. He did not respond to regular antihistamines treatment, but clinical symptoms were relieved by intramuscular injection of compound betamethasone. Skin biopsy showed dermis infiltrated by masses of eosinophils and distinctive "flame figures". Then, diagnosis of eosinophilic cellulitis was made and resolved by glucocorticoid treatment.
Heterotopic Accessory Spleen with Squamous Epithelial Cyst in Pancreas Mimicking Other Pancreatic Tumor: a Case Report

Jieli Luo,Jianshe Chen,Fengbo Huang,Panpan Zhou,Pintong Huang

DOI: https://doi.org/10.21037/atm.2020.03.79

IF: 3.616

2020-01-01

Annals of Translational Medicine

Abstract:A 49-year-old female undergoing a periodic health examination at other hospital revealed a mass in the tail of pancreas. The patient denied any personal history of surgery except subtotal hysterectomy because of multiple myomas in uterus 7 years ago, family history of abdominal cancer and trauma. Physical examination and laboratory finding (including tumor marker) were unremarkable. Chest X-ray result was normal. Contrast enhanced ultrasound (CEUS) examination showed a well-defined hypoechoic pancreatic mass which was suggestive of solid pseudopapillary tumor. Contrast enhanced computed tomography (CE-CT) of the abdomen revealed a mass of hypodensity suggestive of intraductal papillary mucinous neoplasm. Because of the risk of bleeding and exclusion of surgical contraindications, patient underwent laparoscopic surgery. Intraoperatively, a solid mass was identified in the tail of pancreas, the intraoperative frozen pathological examination suggested a heterotopic accessary spleen (HAS) with squamous epithelial cyst. Partial pancreatectomy was performed. The uniqueness of this case is that the spleen can be ectopic to the pancreas, what is even more unexpected is that the HAS undergone cystic change. When encountering a pancreatic mass, we need to think about the possibility of HAS. In conclusion, it is important to diagnose HAS with squamous cyst in the pancreatic tail presenting as other pancreatic masses.
Pancreatitis, Panniculitis, and Polyarthritis Syndrome in Two Patients: A Case Series and Literature Review

Logan Kugathasan,Tony Zhuang,Justin Cheeley,Hope Khan,Audrey B Jernigan,Ketino Kobaidze

DOI: https://doi.org/10.7759/cureus.59471

2024-05-01

Cureus

Abstract:Pancreatitis, panniculitis, and polyarthritis (PPP) syndrome presents a unique challenge in diagnosis and management because of its rarity and heterogeneous initial presentation. This manuscript presents a case series of two patients with PPP syndrome, shedding light on the diagnostic process and care for this uncommon condition. PPP syndrome is characterized by the simultaneous occurrence of pancreatitis or pseudocysts alongside polyarthritis and panniculitis. While its exact pathophysiology remains obscure, pancreatic inflammation is assumed to trigger the hematogenous dissemination of pancreatic enzymes, leading to fat necrosis and subsequent panniculitis, as well as chondronecrosis and/or osteonecrosis causing polyarthritis. Despite its recognition in medical literature since the late 1980s, PPP syndrome remains poorly understood, with only a limited number of cases reported globally. Its rarity and varied initial manifestations often result in misdiagnosis, causing delays in appropriate treatment. The presented case series highlights key clinical features and diagnostic clues of PPP syndrome. Both patients exhibited initial symptoms of inflammatory polyarthritis, accompanied by characteristic findings of "ghost cells" on skin biopsy. Additionally, radiographic and laboratory evidence revealed pancreatic changes consistent with this syndrome. This case series underscores the importance of multidisciplinary collaboration in managing PPP syndrome. Early recognition and accurate diagnosis are pivotal in initiating prompt and effective therapeutic interventions, thereby improving patient outcomes and minimizing long-term sequelae.
Acute Pancreatitis Likely Due to Semaglutide

Katie Hughes,Yovan Ram Kurrun Sumaruth,Elmahi Mohammed,Vibhootee Sant Bakshsingh

DOI: https://doi.org/10.7759/cureus.69844

2024-09-21

Cureus

Abstract:Semaglutide is a glucagon-like peptide-1 receptor agonist (GLP-1RA) that has gained recent popularity in its effective management of type 2 diabetes mellitus (T2DM) and obesity. Minimal evidence has reported the link between Semaglutide use and acute pancreatitis. In this case report, we discuss the case of a 36-year-old female presenting to the Emergency Department with sudden-onset epigastric pain, subsequently diagnosed with acute pancreatitis. Moreover, she had recently started subcutaneous semaglutide injections for weight loss, which she had procured from one of her acquaintances without seeking medical advice. Semaglutide was thus stopped and her lipase levels normalized with significant improvement of her symptoms, making semaglutide the likely causative factor for her acute pancreatitis. Given the increased use of GLP-1RA, we aim to increase awareness among patients taking this medication whether prescribed or not and increase clinician awareness when prescribing this medication.
A 50-year-old patient with pancreatitis revealing pancreatitis, panniculitis, and polyarthritis syndrome-a case report and review of the literature

Katharina Storch,Manuel Bécède,Wolfgang Krampla,Peter Mikosch,Franz Trautinger,Andreas Mayer,Judith Sautner

DOI: https://doi.org/10.1007/s10354-024-01055-7

Abstract:The combination of pancreatitis, panniculitis, and polyarthritis (PPP) is a rare systemic syndrome that occurs in patients with acute or chronic pancreatitis or pancreatic malignancies. A 50-year-old male patient presented with polyarthritis increasing for 1 week and consequent inability to walk unaided. In addition, the patient had several isolated nodules on the lower extremities without any tenderness to pressure. Laboratory tests showed elevated pancreatic enzymes indicative of pancreatitis, which was thereafter confirmed by abdominal CT scan, with signs of chronic pancreatitis and concrements in the pancreatic duct. The diagnosis of panniculitis was established by dermatological consultation. Considering all these clinical features, PPP syndrome was diagnosed. In accordance with the pre-existing literature, oral glucocorticoid therapy and nonsteroidal anti-inflammatory drugs (NSAIDs) were given but failed to improve pain and polyarthritis. In the further clinical course, due to the persistent increase in lipase and amylase, endoscopic retrograde cholangiopancreatography (ERCP) was performed, showing small concrements in the pancreatic duct. During the intervention, the pancreatic duct was widened, the small concrements were removed, and a pancreatic duct stent was then implanted. Following ERCP, an instant decrease in pancreatic enzymes was observed, accompanied by a clear and sustained improvement of joint swellings and pain. With the typical triad of clinical findings in mind, one should consider PPP syndrome in the context of acute or chronic pancreatitis as well as in pancreatic malignancies. All involved disciplines (gastroenterology, dermatology, and rheumatology) should be familiar with this rare but severe condition. The prognosis depends on the extent of the functional deficit of the extremities and the progression of the underlying disease.
Necrolytic migratory erythema caused by pancreatic hyperglycemia with emphasis on therapeutic and prognosis: A case report

Shi-Ping Zhan

DOI: https://doi.org/10.12998/wjcc.v12.i23.5404

2024-08-16

World Journal of Clinical Cases

Abstract:BACKGROUND With the incidence of pancreatic diseases increasing year by year, pancreatic hyperglycemia, as one of the common complications, is gradually gaining attention for its impact on the skin health of patients. CASE SUMMARY This was the case of an elderly female with clinical manifestations of necrolytic migratory erythema, “three more and one less,” diabetes mellitus, hypertension, anemia, hypoproteinemia, and other syndromes, which had been misdiagnosed as eczema. Abdominal computed tomography showed a pancreatic caudal space-occupying lesion, and the magnetic resonance scanning of the epigastric region with dynamic enhancement and diffusion-weighted imaging suggested a tumor of the pancreatic tail, which was considered to be a neuroendocrine tumor or cystadenoma. The patient was referred to a more equipped hospital for laparoscopic pancreatic tail resection. Post-surgery diagnosis revealed a neuroendocrine tumor in the tail of the pancreas. To date, the patient’s general condition is good, and she is still under close follow-up. CONCLUSION Necrolytic migratory erythema can be induced by endocrine system tumors or endocrine metabolic abnormalities, with complex clinical manifestations, difficult diagnosis, and easy misdiagnosis by dermatologists. The initial treatment principles in dermatology include symptomatic supportive therapy and effective drugs to relieve skin lesions. After clarifying the etiology of glucagonoma, comprehensive treatment in collaboration with endocrinologists, general surgeons, and oncologists can help provide individualized treatment for patients and improve their prognosis.

medicine, general & internal
Case Report: Acute Pancreatitis in an Uncontrolled Diabetic Patient Presenting With a Skin Rash Later Found to Be Eruptive Xanthoma, a Dermatological Manifestation and Diagnostic Clue to Recognizing Hypertriglyceridemia as the Cause of Disease

Paul Q Vu,Mrudula Thiriveedi,Siddharth Patel,Rajesh Metuku

DOI: https://doi.org/10.7759/cureus.64563

2024-07-15

Cureus

Abstract:Acute pancreatitis results from any insult that leads to inflammation of the organ. Hypertriglyceridemia is one of the risk factors associated with acute pancreatitis. The typical presentation is abdominal pain, nausea, and vomiting. We present a unique case in which the patient's condition was further complicated by diabetic ketoacidosis. Consequently, he presented somnolent to the emergency room, providing a limited history only pertaining to generalized weakness and a skin rash. The patient was found to have hypertriglyceridemia-induced pancreatitis, which was appropriately managed in the intensive care unit. The skin lesions were diagnosed as xanthomas, which are associated with hypertriglyceridemia and acute pancreatitis secondary to hypertriglyceridemia. The patient was discharged on fibrate therapy, dietary counseling, and strict monitoring by his primary care physician. This unique case highlights the importance of recognizing dermatological conditions and their associated diseases to allow for prompt diagnosis and treatment in the face of limited history.
Exocrine Pancreatic Insufficiency During the Use of Semaglutide: A Case Report

Clivaldo Agra de Melo Junior,Norberto Eloi Gomes Júnior,Marco Aurélio da Silva Ribeiro-Sousa,Selma Freire de Carvalho Cunha

DOI: https://doi.org/10.7759/cureus.55549

2024-03-05

Cureus

Abstract:Although acute pancreatitis has been reported as an adverse event in patients treated with glucagon-like peptide-1 (GLP-1) analogues, to date we have not identified a case describing exocrine pancreatic insufficiency related to this drug. Here we present a case of a patient with no history of acute pancreatitis, who was diagnosed with exocrine pancreatic insufficiency during the third year of weekly subcutaneous semaglutide for obesity control. A 68-year-old man with previous unsuccessful therapeutic approaches for weight loss used subcutaneous semaglutide, once a week, for 181 weeks. The pharmacological treatment, combined with instructions on lifestyle changes, resulted in a weight loss of 11.6% of initial body weight, with a reduction in body mass index from 35.7 to 31.9 kg/m2. The patient received a regular dose of 0.5mg/week in the first 14 weeks in a private physician's office. During this period, an asymptomatic elevation of serum lipase was identified and attributed to alcohol consumption. Because the patient complained of less satiety and weight loss stabilization, the dose of semaglutide was increased to 1.0mg/week. Serum lipase levels increased to up to eight times the upper normal limit and the use of semaglutide was discontinued for 10 weeks. Due to progressive weight regain and serum lipase levels being near normal, semaglutide was reintroduced at 0.25mg/week with progressive increments until 1.0mg/week. The patient missed the follow-up appointments, continued the same dose of semaglutide for another 16 weeks, and discontinued treatment after another asymptomatic elevation in serum lipase levels. Four weeks later, the patient reported steatorrhea and was seen by a gastroenterologist, who diagnosed exocrine pancreatic insufficiency. The course of our case suggests a potential association between semaglutide and chronic alcohol consumption in the development of exogenous pancreatic insufficiency. We call attention to the importance of regular monitoring of serum lipase levels in patients taking GLP-1 analogues and suggest that the consumption of any amount of alcohol should be discouraged in patients in long-term treatment with glucagon-like peptide-1 receptor agonists.
IgG4-Related Autoimmune Pancreatitis Mimicking Pancreatic Cancer: A Report of Two Cases

Fatema Mohamed,Balasubramaniam Vijayan,Lokesh Saraswat

DOI: https://doi.org/10.7759/cureus.65289

2024-07-24

Cureus

Abstract:IgG4-related autoimmune pancreatitis (AIP) is a rare inflammatory condition characterized by elevated IgG4-positive plasma cells and lymphoplasmacytic infiltration in the pancreas. This disease responds to steroid therapy but can be challenging to differentiate from pancreatic cancer. In this paper, we present two cases of IgG4-related AIP presenting as pancreatic masses. Our aim is to highlight the diagnostic complexities of this condition and emphasize the need for a multidisciplinary approach to avoid unnecessary surgical interventions and ensure appropriate treatment.
Immune checkpoint inhibitors-related pancreatitis with fulminant type 1 diabetes mellitus: case report and literature review

Wei Fang,Yang Gao,Xiaoyan Shi,Xiaoran Zhang,Shan Zhou,Hongxia Zhu,Wei Yan,Huanping Wang

DOI: https://doi.org/10.3389/fimmu.2023.1243773

IF: 7.3

2023-09-28

Frontiers in Immunology

Abstract:Immune checkpoint inhibitors (ICIs) are increasingly being used in the treatment of advanced human malignancies. ICIs-related adverse events, including pancreatitis and diabetes, have been individually characterized in the literature. The co-occurrence of ICIs-related pancreatitis with diabetes is rare and easily overlooked, but it is often severe or fatal. We present a patient with renal tumor resection who was treated with injection of the PD-L1 inhibitor toripalimab and eventually developed acute pancreatitis and fulminant type 1 diabetes mellitus. In addition, we conducted a literature review of ICIs-related pancreatitis with diabetes. The case in our report presented with paroxysmal abdominal pain and loss of appetite. Intravenous fluids and insulin infusion improved the patient's pancreatitis and explosive hyperglycemia. This article suggests that ICIs can affect endocrine and exocrine functions of the pancreas, while providing information and new perspectives for the diagnosis and treatment of this challenging rare disease, helping inspire clinicians for the early identification and effective management of similar cases.

immunology
Pancreatic Heterotopia Presenting as a Mimic of Fistulizing Crohn's Disease: Expanding the Differential Diagnosis of Inflammatory Bowel Disease

Yeseena Alli,Jesus S Noain,Wei Shaw,Kelly Brenan

DOI: https://doi.org/10.7759/cureus.68666

2024-09-04

Cureus

Abstract:Pancreatic heterotopia (PH) involves pancreatic tissue located outside its typical anatomical position, lacking vascular or ductal communication with the pancreas. Despite frequently having acini with the capacity to produce digestive enzymes, PH is usually asymptomatic. When symptoms do occur, they typically present in middle to late adulthood and include abdominal pain, nausea, and diarrhea. This clinical presentation is similar to that of Crohn's disease, an autoimmune inflammatory bowel disease (IBD). The presentation of symptomatic PH varies depending on the location of the ectopic pancreatic tissue and its microanatomical constituents, including exocrine and endocrine tissue as well as a duct system. We present a case of a patient who came to medical attention with abdominal pain and was found on colonoscopy to have a non-obstructing stricture of the transverse colon without an associated mass. Biopsies of the area revealed chronic active colitis, leading to a diagnosis of Crohn's disease. Her gastroenterological symptoms remained stable for several years while receiving infliximab infusions until she presented to the emergency department with severe abdominal pain, diarrhea, and sepsis, meeting the criteria for systemic inflammatory response syndrome. Imaging studies revealed a fistula between the previous colonic stricture and the jejunum, again attributed to Crohn's disease. She underwent surgery to remove the fistula between the small and large bowels. Unexpectedly, the resection specimen showed a mass insinuated between the loops of the large intestine, which histological review revealed to be ectopic pancreatic tissue. Following the resection of the ectopic pancreatic tissue, her symptoms resolved without the need for further treatment. In retrospect, the ectopic pancreatic tissue, which contained acini with digestive enzymes, ducts, and islets, may have also caused seemingly unrelated pathology in the patient. Symptomatic PH should be recognized as a pathology that can mimic IBD, prompting reconsideration of the diagnosis in cases of refractory disease while on biologics.
Autoimmune Pancreatitis Associated with a Pancreatic Pseudocyst Treated by Distal Pancreatectomy with Splenectomy: Case Report

Xiao-Bo Xu,Ying-Shen Wu,Wei-Lin Wang,Shu-Sen Zheng

DOI: https://doi.org/10.1186/1477-7819-12-359

2014-01-01

World Journal of Surgical Oncology

Abstract:Autoimmune pancreatitis is a unique type of chronic pancreatitis, which is rarely associated with pseudocyst. A 48-year-old lady was admitted to our department with a rapidly growing cystic mass in the pancreatic tail with an elevated concentration of serum carbohydrate antigen 19-9 (CA19-9). She had a history of autoimmune pancreatitis and received steroid treatment. Imaging studies demonstrated a cystic mass in the pancreatic tail. The mass kept growing despite restoration of steroid treatment. Eventually, the patient underwent distal pancreatectomy with splenectomy. Histopathological examination revealed the existence of pseudocyst, significant lymphocytic infiltration, and fibrotic change in the pancreatic tail.
Bullous Pemphigoid Mimicking Cellulitis

Ilya Ivyanskiy,Dhara Dave,Anass Dweik,James Yeary,Tarek M Naguib

DOI: https://doi.org/10.1177/23247096211008585

Abstract:Bullous pemphigoid (BP) is the most prevalent autoimmune blistering skin disease in the Western world affecting mainly the elderly population. The diagnosis is based on clinical assessment along with specific immunopathologic findings on skin biopsy. Risk factors include genetic factors, environmental exposures, and several infections including hepatitis B, hepatitis C, Helicobacter pylori, Toxoplasma gondi, and cytomegalovirus. A variety of drugs have been associated with BP including but not limited to dipeptidyl peptidase-4 inhibitors, loop diuretics, spironolactone, and neuroleptics. Associated neurologic disorders (dementia, Parkinson's disease, bipolar disorder, previous stroke history, and multiple sclerosis) have also been described. Common clinical presentation consists of extremely pruritic inflammatory plaques that resemble eczematous dermatitis or urticaria, followed by formation of tense bullae with subsequent erosions. Typical distribution involves the trunk and extremities. Mucosa is typically spared affecting only 10% to 30% of patients. Several unusual clinical presentations of BP have been described such as nonbullous forms with erythematous excoriated papules, plaques, and nodules. Other reported findings include urticarial lesions, prurigo-like nodules, multiple small vesicles resembling dermatitis herpetiformis or pompholyx, vegetating and purulent lesions localized in intertriginous areas, and even exfoliative erythroderma. Recognition and management of such cases can present a diagnostic challenge to clinicians. In this article, we describe another variant which to our knowledge is the first case to present with a cellulitis-like presentation in a patient with a known history of BP.
S2528 Uncommon Culprit: Pancreatitis & Biliary Stricture Revealed

Abu Fahad Abbasi,Luqman Baloch,Basil Muhanna,Altaf Dawood,Naser Khan

DOI: https://doi.org/10.14309/01.ajg.0001039480.49335.34

2024-10-26

The American Journal of Gastroenterology

Abstract:Drug-induced pancreatitis makes up less than 3% of all acute pancreatitis cases. We present a case of pembrolizumab-induced pancreatitis with biliary stricture due to immune checkpoint inhibitor (ICI) use.

gastroenterology & hepatology
IgG4-related disease mimicking pancreatic cancer: Case report and review of the literature

Ibnouf Sulieman,Ahmed Mahfouz,Einas AlKuwari,Lajos Szabados,Walid Elmoghazy,Ahmed Elaffandi,Hatem Khalaf

DOI: https://doi.org/10.1016/j.ijscr.2018.07.030

Abstract:Introduction: Most patients with pancreatic masses pose a diagnostic challenge when a benign lesion is suspected, and often, resection is needed before a benign diagnosis is confirmed. Presentation of case: A 57 years old male patient presented with a pancreatic head mass, obstructive jaundice and submandibular lymph node enlargement. He also had a history of recurrent eye pain and redness, skin lesions, and benign prostatic hypertrophy. MRI showed a pancreatic head mass with double duct sign, aortic thickening, bilateral renal lesions, diffuse lymph node enlargement, and prostatic enlargement. FDG-PET/CT demonstrated abnormal uptake corresponding to the MRI lesions, and there were elevated IgG4 levels on blood investigations. Biopsy of an inguinal lymph node revealed infiltrates with IgG4 plasma cells, consistent with the diagnosis of IgG4 disease. The patient was treated with IV steroids and showed significant improvement. Discussion: IgG4 related disease is a rare entity that is characterized by lesions that show heavy infiltration with IgG4 positive plasma cells, storiform fibrosis, and obliterative phlebitis. The pancreas is the most commonly involved organ, but several other organ systems are involved, and this helps in clinical suspicion of the diagnosis. A biopsy from any easily accessible site that shows the characteristic histological features is sufficient for diagnosis. Patients respond quickly to steroids, but recurrence is frequent. Conclusion: IgG4 related disease is a rare cause of pancreatic tumorous lesions that need a high index of suspicion for diagnosis and should be differentiated from pancreatic neoplastic lesions.
Semaglutide-Induced Lupus Erythematosus With Multiorgan Involvement

Vanessa Castellanos,Hiwot Workneh,Ayesha Malik,Bijal Mehta

DOI: https://doi.org/10.7759/cureus.55324

2024-03-01

Cureus

Abstract:We report the case of a 76-year-old female who presented with a new onset of petechial rash in her lower extremities after the introduction of a new agent, semaglutide. She started taking this medication three months before her presentation at an initial dosage of 0.5 mg subcutaneously every week. She noticed a 15-pound weight loss and debilitating fatigue within that timeframe. She stopped taking the medication due to nontolerance and GI upset (nausea and vomiting) about a week before her hospitalization. She denied the use of any other agents. Initial lab work revealed elevated transaminases, alkaline phosphatase, total bilirubin, and inflammatory markers. A CT of the abdomen revealed mild cirrhosis and hepatosplenomegaly. Other causes for cirrhosis were effectively ruled out with negative viral hepatitis, ceruloplasmin levels, and the HFE gene. An autoimmune panel was conducted, yielding positive antinuclear antibody (ANA), anti-histone antibodies, elevated double-stranded DNA, as well as low complement levels supporting evidence of drug-induced lupus (DIL). Anti-mitochondrial M2 and anti-smooth antibodies were also detected, indicating a possible overlap syndrome with autoimmune hepatitis. Perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) and anti-neutrophil cytoplasmic autoantibodies (C-ANCA) were negative and ruled out the possibility of ANCA-associated vasculitis. The patient's condition improved with pulse-dose steroids, leading to an improvement in liver function tests. Consequently, the decision to perform skin and liver biopsies was deferred. She was discharged with a tapering dose of steroids and scheduled for outpatient follow-up to monitor her progress. This case report can offer insights to healthcare providers regarding the potential side effects of GLP-1 RAs in their patient population.
S2608 Capecitabine-Induced Hypertriglyceridemia Leading to Pancreatitis: A Rare Presentation

Shriraj S. Patel,Malak S. Al-Bitar,Deepa S. Kumarjiguda,Elisabeth S. Kramer

DOI: https://doi.org/10.14309/01.ajg.0001039800.29275.33

2024-10-26

The American Journal of Gastroenterology

Abstract:Pancreatitis, an inflammatory condition of the pancreas, has a wide range of etiologies, including hypertriglyceridemia-induced pancreatitis (HTGP), which accounts for 1 to 35% of cases. While secondary hypertriglyceridemia is often linked to medications, particularly chemotherapeutic agents, capecitabine-induced pancreatitis has rarely been described. Here, we present a unique case of capecitabine-induced hypertriglyceridemia causing pancreatitis, an occurrence seldom reported in medical literature.

gastroenterology & hepatology
An Unusual Case of Cellulitis in a Patient With Systemic Lupus Erythematosus

Alex Rivero,Megan Shaughnessy,Amanda Noska

DOI: https://doi.org/10.1093/cid/ciad717

IF: 20.999

2024-03-22

Clinical Infectious Diseases

Abstract:A 56-year-old woman with systemic lupus erythematosus (SLE) on mycophenolate sodium, prednisone, and hydroxychloroquine sulfate presented with a 1-week history of left posterior thigh pain and swelling. On admission, she was febrile (39.5°C) but otherwise hemodynamically stable. Examination of the posterior left thigh showed a large, erythematous, indurated plaque that was warm to the touch and tender to palpation (Figure 1). Laboratory results showed pancytopenia, including severe neutropenia, with an absolute neutrophil count of 0.18 k/cmm. She was started on vancomycin and cefepime for neutropenic fever and left lower extremity cellulitis. Computed tomography (CT) of the left lower extremity revealed infiltrative edema and skin thickening of the proximal thigh. CT also showed an incidental infiltrative fluid collection in the left lower quadrant abdominal wall with small foci of internal gas (Figure 2). She later confirmed new pain in this area as well. Surgery was consulted, and she underwent incision and drainage for management of a presumed necrotic skin/soft tissue infection of her abdominal wall. Intraoperative tissue and fluid were obtained for histopathology and microbiology evaluation. No necrosis was seen intraoperatively. A punch biopsy of the skin from the left posterior thigh was also obtained. The histopathology showed the implicated organism in Figure 3, and tissue cultures of both the abdominal wall and thigh confirmed the diagnosis.

immunology,infectious diseases,microbiology
Immunoglobulin G4-Related Disease Presenting as Recurrent Acute Pancreatitis

Vaibhavi A Gor,Krutik J Brahmbhatt,Nachiket Patel,Neel R Vaidya,Vasuprada Narasimhan,Divya A Mehta

DOI: https://doi.org/10.7759/cureus.68844

2024-09-07

Cureus

Abstract:Immunoglobulin G4-related disease (IgG4-RD) is a rare immune-mediated disease affecting multiple organs and tissues. There is often the presence of elevated serum Ig4 subtype with histological evidence of lymphoplasmacytic infiltration, fibrosis, and phlebitis. The mainstay of treatment is steroid therapy. This case report is based on a 24-year-old man with IgG4-related type 1 autoimmune pancreatitis (AIP) who also had elevated serum IgG4 subclass and histological features in keeping with IgG4-RD. The main complaints were dry cough, nasal congestion with sneezing, sore throat, and fever. Necessary investigations were performed and based on the International Consensus Diagnostic Criteria, the diagnosis of AIP type 1 was confirmed, which is a pancreatic manifestation of IgG4-RD. He was subsequently treated with prednisolone and azathioprine and is showing a good response to the treatment.
A Curious Case of Autoimmunity, Pancytopenia, and Disseminated Intravascular Coagulation

Manisha Ghosh Roy,Aradhya Sekhar Bagchi,Ananda Bagchi,Asim Kumar Pal,Chandramouli Mukherjee

DOI: https://doi.org/10.59556/japi.72.0497

Abstract:History and examination: A 21-year-old female patient presented to us with severe low back pain for 4 months. On examination, patient was afebrile, with severe pallor, and tenderness in both sacroiliac (SI) joints. Patient was being admitted and evaluated, and during the course of evaluation, developed severe headache, which was severe in intensity and associated with nausea and projectile vomiting. Initial investigations: An X-ray of the bilateral SI joints revealed inflammation, and the antinuclear antibody (ANA) turned out to be 4+ with pancytopenia and raised lactate dehydrogenase (LDH), but the liver function tests were normal. Rest of the rheumatological profile was unremarkable. During the course of the evaluation, she developed a severe headache, which, on imaging, showed presence of cerebral edema with chronic subdural hematoma, and a concomitant coagulopathy workup revealed evidence of disseminated intravascular coagulation (DIC). Discussion: Taking the whole picture into consideration, a malignant process in the body was suspected, and serum tumor markers carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), and cancer antigen 125 (CA-125) were sent, all of which were raised. Validating the clinical clue was the bone marrow biopsy done for pancytopenia, which revealed malignant epithelial infiltration. A contrast-enhanced computed tomography (CECT) thorax and whole abdomen were done to find out the primary, which showed a neoplastic mass at the gastroesophageal junction along with bony metastases in the vertebrae and left adrenal. Tissue from the primary lesion was taken for histopathological examination (HPE) through upper gastrointestinal endoscopy. Although HPE revealed grade III poorly differentiated stomach adenocarcinoma, the patient had succumbed to the disease process by the time the diagnosis came to light. Conclusion: In short, this case perfectly illustrates how solid organ malignancies might be a mimicker of multisystem disorders, thereby delaying diagnosis and worsening the prognosis even further.

Pancreatic Panniculitis Mimicking Bilateral Cellulitis: A Case Report

A Case of Bullous Eosinophilic Cellulitis

Heterotopic Accessory Spleen with Squamous Epithelial Cyst in Pancreas Mimicking Other Pancreatic Tumor: a Case Report

Pancreatitis, Panniculitis, and Polyarthritis Syndrome in Two Patients: A Case Series and Literature Review

Acute Pancreatitis Likely Due to Semaglutide

A 50-year-old patient with pancreatitis revealing pancreatitis, panniculitis, and polyarthritis syndrome-a case report and review of the literature

Necrolytic migratory erythema caused by pancreatic hyperglycemia with emphasis on therapeutic and prognosis: A case report

Case Report: Acute Pancreatitis in an Uncontrolled Diabetic Patient Presenting With a Skin Rash Later Found to Be Eruptive Xanthoma, a Dermatological Manifestation and Diagnostic Clue to Recognizing Hypertriglyceridemia as the Cause of Disease

Exocrine Pancreatic Insufficiency During the Use of Semaglutide: A Case Report

IgG4-Related Autoimmune Pancreatitis Mimicking Pancreatic Cancer: A Report of Two Cases

Immune checkpoint inhibitors-related pancreatitis with fulminant type 1 diabetes mellitus: case report and literature review

Pancreatic Heterotopia Presenting as a Mimic of Fistulizing Crohn's Disease: Expanding the Differential Diagnosis of Inflammatory Bowel Disease

Autoimmune Pancreatitis Associated with a Pancreatic Pseudocyst Treated by Distal Pancreatectomy with Splenectomy: Case Report

Bullous Pemphigoid Mimicking Cellulitis

S2528 Uncommon Culprit: Pancreatitis & Biliary Stricture Revealed

IgG4-related disease mimicking pancreatic cancer: Case report and review of the literature

Semaglutide-Induced Lupus Erythematosus With Multiorgan Involvement

S2608 Capecitabine-Induced Hypertriglyceridemia Leading to Pancreatitis: A Rare Presentation

An Unusual Case of Cellulitis in a Patient With Systemic Lupus Erythematosus

Immunoglobulin G4-Related Disease Presenting as Recurrent Acute Pancreatitis

A Curious Case of Autoimmunity, Pancytopenia, and Disseminated Intravascular Coagulation